1 Min Read
* SAYS DRUG IS INDICATED FOR TREATMENT OF MODERATE TO SEVERE DEMENTIA OF ALZHEIMER'S TYPE Source text: bit.ly/2oh09C4 Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.